Anti-double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis

被引：25

作者：

Bonaci-Nikolic, B. ^{[1
]}

Jeremic, I. ^{[2
]}

Andrejevic, S. ^{[1
]}

Sefik-Bukilica, M. ^{[3
]}

Stojsavljevic, N. ^{[4
]}

Drulovic, J. ^{[4
]}

机构：

[1] Clin Ctr Serbia, Inst Allergy & Clin Immunol, Belgrade 11000, Serbia

[2] Univ Belgrade, Sch Med, Inst Biochem, Belgrade, Serbia

[3] Inst Rheumatol, Belgrade, Serbia

[4] Clin Ctr Serbia, Inst Neurol, Belgrade 11000, Serbia

来源：

LUPUS | 2009年 / 18卷 / 01期

关键词：

anti-dsDNA; IFN-beta; lupus; multiple sclerosis; DRUG-INDUCED LUPUS; ERYTHEMATOSUS; ALPHA;

D O I：

10.1177/0961203308093550

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present a 43-year-old woman with relapsing-remitting multiple sclerosis (MS) who developed lupus syndrome after 32 months of IFN-beta-1a therapy. She presented with malaise, myalgia, arthralgia and fever. Laboratory tests showed high erythrocyte sedimentation rate, anaemia and lymphopenia. Antibodies to double stranded DNA (dsDNA) of IgG, IgM and IgA classes were detected on Critidia luciliae. Additionally, high levels of anti-nucleosomal antibodies, low levels of anti-histone and anti-Ro/SSA antibodies were also found. Diagnosis of drug-induced SLE was established. Treatment with IFN-beta was discontinued and oral prednisone was started. Twelve weeks after cessation of IFN-beta therapy, the patient's symptoms completely resolved and autoantibodies disappeared. To the best Of Our knowledge, this is the first report of a patient with MS in whom treatment with IFN-beta induced lupus syndrome and antibodies to dsDNA and nucleosome. Lupus (2009) 18, 78-80.

引用

页码：78 / 80

页数：3

共 13 条

[1] Autoimmunity through cytokine-induced dendritic cell activation [J].

Banchereau, J ;

Pascual, V ;

Palucka, AK .

IMMUNITY, 2004, 20 (05) :539-550

[2] Syndromes and complications of interferon therapy [J].

Borg, Frances A. Y. ;

Isenberg, David A. .

CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (01) :61-66

[3] Microglial production of TNF-alpha is induced by activated T lymphocytes - Involvement of VLA-4 and inhibition by interferon beta-1b [J].

Chabot, S ;

Williams, G ;

Yong, VW .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :604-612

[4] Drug-induced lupus due to anti-tumor necrosis factor α agents [J].

Costa, Michelle F. ;

Said, Nuha R. ;

Zimmermann, Bernard .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (06) :381-387

[5] Systemic lupus erythematosus induced by therapy with interferon-β in a patient with multiple sclerosis [J].

Crispín, JC ;

Díaz-Jouanen, E .

LUPUS, 2005, 14 (06) :495-496

[6] Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity - Biologic and clinical implications in autoimmune arthritis [J].

De Rycke, L ;

Baeten, D ;

Kruithof, E ;

Van den Bosch, F ;

Veys, EM ;

De Keyser, F .

ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2192-2201

[7] Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis [J].

Jaekel, H-P ;

Trabandt, A. ;

Grobe, N. ;

Werle, E. .

LUPUS, 2006, 15 (06) :335-345

[8] Rare association of multiple sclerosis and systemic lupus erythematosus [J].

Kyrozis, A. ;

Kararizou, E. ;

Georgila, E. ;

Loukaidis, P. N. ;

Koureas, A. ;

Rombos, A. ;

Sfagos, C. ;

Vassilopoulos, D. .

LUPUS, 2007, 16 (12) :991-992

[9] Interferon-beta - Mechanism of action and dosing issues [J].

Markowitz, Clyde E. .

NEUROLOGY, 2007, 68 :S8-S11

[10] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS [J].

POSER, CM ;

PATY, DW ;

SCHEINBERG, L ;

MCDONALD, WI ;

DAVIS, FA ;

EBERS, GC ;

JOHNSON, KP ;

SIBLEY, WA ;

SILBERBERG, DH ;

TOURTELLOTTE, WW .

ANNALS OF NEUROLOGY, 1983, 13 (03) :227-231

← 1 2 →